Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04564157
Title NADIM-ADJUVANT: New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy (NADIM-ADJUVANT)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Fundacion GECP
Age Groups: adult | senior
Covered Countries ESP

Additional content available in CKB BOOST